Oral Fluid Nanosensor Test (OFNASET) with Advanced Electrochemical-Based Molecular Analysis Platform
High-impact diseases, including cancer, cardiovascular disease, and neurological disease, are challenging to diagnose without supplementing clinical evaluation with laboratory testing. Even with laboratory tools, definitive diagnosis often remains elusive. The lack of three crucial elements presents a road block to achieving the potential of clinical diagnostic test
salivary diagnostics electrochemical detection cyclic enzymatic reaction bionanotechnology genetic assay immunoassay simultaneous multichannel detection point-of-care pcr-less detection ultrasensitive detection